GILD -5%/AH on 1Q18 results—HCV sales=$1.05B: https://finance.yahoo.com/news/gilead-sciences-announces-first-quarter-200100189.html Full-year 2018 guidance for revenue and non-GAAP EPS remain unchanged from the values given in February.